Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.65 USD | +5.16% | +5.58% | -37.05% |
26/04 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
25/04 | Leerink Partners Downgrades CureVac to Market Perform From Outperform, Sets Price Target at $4 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.05% | 594M | |
+0.67% | 42.4B | |
+46.79% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- Sector Update: Health Care Stocks Steady Premarket Thursday